If you believed the pandemic was finally over, you were mistaken, It has reared its ugly head by releasing Omicron, a new variant.
Dolo 650 is now India’s favoured paracetamol brand, with sales of Rs 567 crore since March 2020. It’s even trending on social media and is the subject of memes.
Since COVID-19 cases have been on the rise, demand for the drug Dolo 650 has been high.
As India grapples with the third wave of Covid, Dolo 650, which has clocked sales of Rs 5.7 billion during the pandemic since March 2020 and topped the charts of paracetamol pill, has been dubbed a "favourite snack."
Fever, one of the most common symptoms of COVID-19, has pushed sales of this oval-shaped white pill to treble in the last two years, despite the fact that paracetamol pills are the most commonly used cold and fever treatments.
What Made Dolo Popular?????
The first reason shared by doctors, brand experts and industry veterans is it’s short and crisp brand name. It’s simpler than other brands such as Pyrigesic, Pacimol, Fepanil and Paracip.
Another reason is the company’s entry into the 650 milligram (MG) category and perception that it’s more effective on fever due unknown illnesses.
Founded in 1973, Bengaluru-based Micro labs -maker of brand Dolo- sensed the opportunity and relaunched the product emphasising that it contained 650 mg of paracetamol, while the rest had 500 mg.
The medicine became popular as “Dolo-650".
Source: Pratima Gedela